MDSANZ Movement Disorders Therapeutics Practical Workshop 2020

24-25 October 2020
Westmead Education and Conference Centre
Westmead Hospital, Sydney

Speakers



           

Dr Jeffrey Blackie

Dr Jeffrey Blackie is a Senior Staff Neurologist at John Hunter Hospital and Lecturer at Newcastle University. He graduated from the UNSW in 1978 and obtained his FRACP in 1984 in General Medicine. He obtained a Commonwealth Medical Fellowship to enable further study at Queen Square, London from 1986-1989 before returning to Newcastle. He became a member of the Australian Association of Neurologists in 1989. His subspecialty interests are Clinical Neurophysiology and Movement Disorders. He has been using Botulinum Toxin to treat patients since 1987 (33years!) and has been involved in a number of clinical trials assessing this agent including cervical dystonia, laryngeal dystonia and neuralgia.

 

Dr Florence Chang

Dr Florence Chang completed her medical degree at the University of New South Wales with Honours in 2002. She completed basic physician training in St Vincent Hospital, then neurology training at Royal North Shore and Westmead Hospital, before completing John Morris Movement Disorder fellowship at Westmead hospital in 2013. She worked as a neurology fellow at Mayo Clinic Rochester USA and movement disorder fellow (awarded by the Dystonia Medical Research Foundation) at Mount Sinai Medical Center, New York, USA.

 

She has submitted her doctorate thesis in 2019, studying the movement and postural control of dystonia patients. She is working as a movement disorder neurologist at Westmead Hospital and involved in clinical research in long term observational study for idiopathic adult onset dystonia and clinical trials for gene-silencing therapy for Huntington's disease.

 

Emma Everingham

Emma is passionate about being a Neuroscience nurse, with experience in our public, community and private hospital sectors.

Specialising initially in neurosurgical nursing, followed by community care of adults and children with cerebral palsy. For the past six years Emma has expanded her skills as a nurse practitioner in Movement Disorders at Westmead Hospital, with a special interest in NPH and DBS and promoting the scope of the Nurse Practitioner.

   

Dr Victor Fung

Dr Victor Fung is Clinical Associate Professor at Sydney Medical School, The University of Sydney, and Director of the Movement Disorders Unit and Head, Department of Neurology, Westmead Hospital in Sydney, Australia. He is Co-Chair of the Publications and Communications Oversight Committee of the International Parkinson and Movement Disorder Society, and has been a past Treasurer and past Chair of its Congress Scientific Program Committee. He is on the Educational Committee of the International Association of Parkinson's and Related Disorders, the Asian Oceanian Association of Neurology Education Committee, and the Asia Pacific Affairs Committee of the Australian and New Zealand Association of Neurologists, and is a past-President of the Movement Disorder Society of Australia and New Zealand (MDSANZ). He was the founding Chairperson of the MDSANZ Clinical Research and Trials Group. He is a member of the Parkinson's Australia, Parkinson's NSW and Dystonia Network Australia Scientific Advisory Boards. He serves on the Editorial Board of Movement Disorders, npj Parkinson's Disease, the Journal of Clinical Movement Disorders, Movement Disorders Clinical Practice and F1000 Research. He has a clinical and research interest in Parkinson's disease and movement disorders.

               

Dr Ainhi Ha              

Dr Ainhi Ha is a staff specialist neurologist in the Movement Disorders Unit at Westmead Hospital, and a clinical senior lecturer at the University of Sydney medical school. She completed her training at Royal North Shore and Westmead Hospitals, before undergoing a clinical fellowship at the Parkinson's Disease Center and Movement Disorder Unit at Baylor College of Medicine in the United States, where she published several first-author publications in international peer-reviewed journals, in addition to reviews, book chapters and other resources in movement disorders. On return to Australia, she completed an NHMRC-funded PhD researching the molecular biological aspects of Parkinson's disease.

 


Dr Michael Hayes               

Dr Michael Hayes is a consultant neurologist and head of department at Concord Hospital, Sydney. His speciality interests are movement disorders, clinical electrophysiology and functional-neuropsychiatric disorders.

 


Dr Thomas Kimber

Dr Thomas Kimber is Clinical Associate Professor in the School of Medicine, Adelaide University and Consultant Neurologist and Head of the Movement Disorders Service of the Neurology Unit, Royal Adelaide Hospital.

His main research interest is the development of new therapies for the management of Parkinson's Disease and related conditions.

He is the current President of the Movement Disorders Society of Australia and New Zealand.


Dr Alexander Lehn 

Dr Alexander Lehn completed his medical degree in Germany and fellowship training in movement disorders and dementia in Australia and United Kingdom. He currently leads the Movement disorders service at the Princess Alexander hospital in Brisbane, and is also a senior lecturer in Medicine at The University of Queensland. Together with Dr. Sarah Olson he heads the Deep Brain Stimulation service at Princess Alexandra Hospital and Mater Hospital in Brisbane. 


Dr Neil Mahant

Dr Neil Mahant is a Movement Disorders Neurologist, trained in Sydney and Toronto by international leaders in the field, including Professor John Morris, Prof Tony Lang and Prof Andres Lozano. His movement disorders interests include the phenomenology of movement disorders, uncommon conditions and in particular advanced therapeutics.

He has a research interest in the physiology of the basal ganglia. He has extensive experience with botulinum toxin and device assisted therapies for movement disorders.

Dr Jacqueline McMaster

Dr Jacqueline McMaster is an Australian born and educated neurosurgeon. She completed a Bachelor of Science degree at the University of Sydney and went on to receive her postgraduate medical degree from the University of Newcastle in 1998. Dr McMaster completed her neurosurgical training at Westmead Adults and Children's and Royal Prince Alfred Hospitals in Sydney and was awarded the Fellowship of the Royal Australasian College of Surgeons (FRACS) in Neurosurgery in 2008.

Dr McMaster has advanced fellowship training in stereotactic and functional neurosurgery, obtained from the University of British Columbia in Canada. Following the completion of her Fellowship in Canada, Dr McMaster returned to Australia to take up a position as a consultant neurosurgeon at Westmead Hospital. She offers treatment in a wide variety of neurosurgical disorders, with a special interest in movement disorders.

Dr McMaster is a fellow of the Royal Australasian College of Surgeons, the Neurosurgical Society of Australasia, the Asian-Australasian Society for Stereotactic and Functional Neurosurgery and the World Society for Stereotactic and Functional Neurosurgery.


Dr Elizabeth Pepper 

Dr Elizabeth Pepper trained in movement disorders at Westmead Hospital, Sydney. She is now director of neurology at JHH with clinical interests including stroke and movement disorders. After a hiatus of 10 years she recommenced treating patients with botulinum toxin injections in 2019.


Dr Paul Silberstein

Dr Paul Silberstein is a Senior Staff Specialist Neurologist at Royal North Shore Hospital and a VMO to North Shore Private Hospital, Sydney Australia.  He is the Practice Principal of Integrated Neurology, a group Neurology and Rehabilitation Medicine private practice.

Dr Silberstein undertook Neurology training at St. George and Westmead Hospitals, Sydney and the Royal Free Hospital, London, UK, prior to undertaking a clinical and research Fellowship at the National Hospital for Neurology and Neurosurgery, Queen Square, London where he completed a Doctorate of Medicine (MD) in Parkinson's disease and Dystonia.

Dr Silberstein's clinical practice focusses on the evaluation and management of Parkinson's disease and Movement disorders. He has extensive experience in the provision of all medical and surgical therapies for Movement disorders including device assisted therapies for the management of Parkinson's disease.  He has particular expertise in Deep Brain Stimulation and has treated over 550 patients with this therapy. His DBS practice includes patient evaluation for surgery; intraoperative targeting, neurophysiologic and clinical assessment; and long-term DBS programming.  

Dr Silberstein is the clinical lead to the Movement Disorder meeting at RNSH where challenging diagnostic and management problems are presented and discussed in a multi-disciplinary forum. He presents regularly at clinical meetings and patient support groups and has published extensively in leading international Neurology journals including Brain and Nature Neuroscience. Dr Silberstein maintains an educational website on Deep Brain Stimulation www.sydneydbs.com and writes regularly on Parkinson's disease for social media www.facebook.com/treatmentsforPD and www.twitter.com/Therapies4PD.


Dr Stephen Tisch

Dr Stephen Tisch graduated from the University of Tasmania in Medicine with first class honours. He completed neurology residency at St Vincent's Hospital Sydney and the Mayo Clinic Rochester Minnesota USA. He trained in movement disorders and deep brain stimulation (DBS) at The National Hospital for Neurology Queens Square with a PhD on pallidal DBS for dystonia from University College London.

Dr Tisch is a Consultant Neurologist and Head of Department of Neurology at St Vincent's Hospital Sydney, and Conjoint Associate Professor University of NSW. He is also Adjunct Clinical Associate Professor at the University of Notre Dame Medical School. His areas of special interest are movement disorders, DBS and MRI guided focused ultrasound (MRgFUS). In 2017 he competed 6 months sabbatical at l'hopital Salpetriere Paris and studied MRgFUS at two European centres.

 

He has authored or co-authored over 60 peer-reviewed articles and two book chapters. He serves on the advisory committee for Parkinson's NSW and Dystonia Network Australia and is the Treasurer of the Australian Movement Disorders Society.


David Tsui

David Tsui is the Clinical Nurse Consultant in Parkinson's & Movement Disorders at Westmead Hospital, NSW. Since 2008, he has had extensive experience in the field of Movement Disorders. Completing the Masters of Nursing in 2014, he was endorsed as a Nurse Practitioner in 2017. Working in collaboration with a Neurologist in private practice, David provides a Nurse Practitioner led Deep Brain Stimulation clinic. In addition to these specialized clinical roles, David is the tutor/marker for the Australian College of Nursing Post Graduate Certificate subject 'Parkinson's Care', as he is a key author of this subject. He is also a guest lecturer at the University of Sydney.  Since 2016, David has been an integral committee member of the Movement Disorders Chapter of ANNA.


Sue Williams

Sue Williams, has been the Parkinson's Clinical Support Nurse at Royal North Shore since 2009 and a Fellow of the Australian College of Nursing since 2018. Sue provides expert clinical assessment, ongoing support, and education to patients with movement disorders and their carers. She has expertise in both Apomorphine and Duodopa.

Concurrent with her clinical work Sue is currently a founding committee member of the Movement Disorder Chapter of the Australasian Neuroscience Nurse Association. The Chapter not only aims to provide professional and clinical support to specialist PD nurses and reduce geographical isolation but also promote a professional identity for movement disorder nurses in the region.


Professor Con Yiannikas

Professor Con Yiannikas is currently a Clinical Professor of Neurology at Sydney University, Senior Visiting Neurologist at the Concord Repatriation General Hospital and Royal North Shore Hospital. He is director of Inner West Neurology a private centre with clinics specializing in neurophysiology, neuromuscular disease, multiple sclerosis, botulinum toxin and movement disorders.

Con did his clinical neurology training at Concord and Royal North Shore Hospitals Sydney and subsequently fellowships in clinical neurophysiology at Royal Prince Alfred Hospital and the Massachusetts General Hospital Boston between 1978 and 1983.

He has previously served as a member of the scientific program committee for the Australian Association of Neurologists and the Australian Movement Disorders Society (Chair 1993-4).

He was a member of the Clinical Neurophysiology sub-committee of the Australian Association of Neurologists and in 2006 founded the Sydney neurophysiology workshop.

He has a strong interest in education and provides postgraduate education in neurophysiology and botulinum toxin injection techniques. His research interests have included neurophysiological assessment of movement disorders, the clinical applications of Botulinum toxin, the origins of evoked potentials and their clinical application in addition to research in multiple sclerosis, neuromuscular diseases including motor neuron disease and inflammatory demyelinating neuropathies.